Add To Watchlist
Share URL
About The Company
CEO
Dr. Ludwig Hantson
Market Cap
NaN undefined USD
Sector
Healthcare
Website
http://www.alexion.comLast Update
2/22/2024, 12:00:00 PM
Description
Alexion Pharmaceuticals, Inc.
Read More
Overview
Value
51
Growth
31
Health
79
Management
31
Analyst Opinion
86
Total
56
All Scores Out Of 100
Best Features
- Has a low level of debt
- Has a history of share buybacks
- Has strong financial health
- Liked by analysts
- Low preportion of income is paid as dividend
Risk Factors
- Earnings have declined recently
- Disliked by Twitter users
- Poor earnings and cashflow growth
- Price-to-earnings ratio of 58.1 is higher than the market average (19.6x)
- Dividend could be at risk
Market Peers
ALXN
Key Figures
PE Ratio (TTM)
58.12
Margin Of Safety (DCF)
N/A
Revenue Growth (5 Year Average)
4.83%
Ratings Consensus
Strong Buy
Share Buybacks
0.11%
Dividend Yeild (TTM)
N/A
Valuation
Value Score
51
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: N/ANaNNaN
Current Price: 182.5 USD
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
58.12x
Free Cashflow Yeild
N/A
PE/Earnings Growth
3.24
Price/Book
Infinityx
Growth
Growth Score
31
- ✔ Revenue growth has improved this yeara
- ✔ Free Cashflow growth has improved this year
- ✘ 5 Year Average Revenue growth of 4.83% is lower than the market average (10.97%)
- ✘ 5 Year Average Earnings growth of -2.38% is lower than the market average (14.48%)
- ✘ Earnings growth has slowed this year
- ✘ 5 Year Average Free Cashflow growth of 10.33% is lower than the market average (12.35%)
Revenue Growth
4.83%
Earnings Growth
-2.38%
Cashflow Growth
10.33%
Health
Health Score
79
Altman Z Score
N/A
Piostroski Score
N/A
Debt/Equity
0.20x
Current Assets/Liabilities
4.52x
Free Cashflow/Total Debt
0.20x
Debt/Capital
0.39x
Dividend
Secure Dividend Score
0
- ✔ Long term dividend payout ratio of 0.00% is considered good
- ✔ Payout ratio (TTM) of 0.00% is lower than the average (40%)
- ✔ Dividends have shown growth over the last 5 years
- ✔ Spending a lower percentage of their income on dividends than last 5 years
- ✘ Dividend yeild of N/A is less than the market average (1.85%)
- ✘ Very unsafe
Dividend Yeild
N/A
Dividend Growth
0.00%
Payout Ratio (Earnings)
0.00%
Payout Ratio (Cashflow)
0.00%
Management
Management Score
31
Average Buybacks/Dilution
0.11%
Recent Buybacks/Dilution
-100.00%
5 Year Price Volitility
15.41%
Return On Assets
0.00%
Return On Capital Employed
4.62%
Return On Equity
0.00%
Return On Free Cashflow
N/A
Return On Investments
0.00%
Analysts
Analyst Opinion
86
- ✔ Ratings consensus is Strong Buy
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Alexion Pharmaceuticals, Inc.
Currency
USD
Beta
1.259521
Vol Avg
4222993
Ceo
Dr. Ludwig Hantson
Cik
0000899866
Cusip
015351109
Exchange
Nasdaq Global Select
Full Time Employees
3837
Industry
Biotechnology
Sector
Healthcare
Ipo Date
1996-02-01
Address
121 Seaport Blvd
City
Boston
State
MASSACHUSETTS
Country
US
Zip
02210
Phone
14752302596
Analysis Last Updated
2/22/2024, 12:00:00 PM
All financial data provided by FMP
Social Sentiment
Social Sentiment Score
0
Twitter Sentiment
N/A
Stocktwits Sentiment
N/A